CBL mutations promote activation of PI3K/AKT signaling via LYN kinase
Sebastian H.J. Koochaki,
Namrata D Udeshi,
Steven A Carr,
Benjamin L Ebert
Posted 14 Apr 2020
bioRxiv DOI: 10.1101/2020.04.13.038448
Posted 14 Apr 2020
CBL encodes an E3 ubiquitin ligase and signaling adaptor that acts downstream of cytokine receptors. Recurrent CBL mutations occur in myeloid malignancies, but the mechanism by which these mutations drive oncogenesis remains incompletely understood. Here we performed a series of studies to define the phosphoproteome, CBL interactome and molecular mechanisms of signaling activation in cells expressing an allelic series of CBL mutants. Our analyses revealed that increased LYN activation and interaction with mutant CBL are key drivers of enhanced PIK3R1 recruitment and downstream PI3K/AKT signaling in CBL-mutant cells. Furthermore, we demonstrated in vitro and in vivo efficacy of LYN inhibition by dasatinib in CBL-mutant cell lines and primary chronic myelomonocytic leukemia cells. Overall, our data provide rationale for exploring the therapeutic potential of LYN inhibition in patients with CBL-mutated myeloid malignancies. ### Competing Interest Statement B.L.E. has received research funding from Celgene and Deerfield and serves on the scientific advisory boards for Skyhawk Therapeutics and Exo Therapeutics. The remaining authors declare no potential conflicts of interest.
- Downloaded 667 times
- Download rankings, all-time:
- Site-wide: 46,348
- In cancer biology: 1,288
- Year to date:
- Site-wide: 31,163
- Since beginning of last month:
- Site-wide: 56,098
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!